Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fmicb.2022.998287
PubMed Identifier: 36312942
Publication URI: http://europepmc.org/abstract/MED/36312942
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in microbiology
ISSN: 1664-302X